Ticker LaunchReverse merger · Pending
Mentari Therapeutics, Inc.
Reverse merger with InMed Pharmaceuticals Inc. (INM)
Mentari Therapeutics, Inc. agreed to merge into InMed Pharmaceuticals Inc. (INM), in a reverse merger that takes the private company public. The deal was announced on May 19, 2026.
- Status
- Pending
- Private company
- Mentari Therapeutics, Inc.
- Public company
- InMed Pharmaceuticals Inc. (INM)
- Announced
- May 19, 2026
- Exchange
- Nasdaq
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Press release amendment and S-4 Jul 6, 2026
- S-4/A (registration/proxy) Sep 29, 2026
- All filings on EDGAR CIK 1728328
Other pending reverse mergers
- Noble Africa LLC (ASP Isotopes subsidiary holding Renergen)into ENDRA Life Sciences Inc. · Jun 25, 2026
- Remix Therapeutics, Inc.into Passage Bio, Inc. · Jun 24, 2026
- Fortitude Mining Holdings, Inc. (Fortitude Mining HoldCo, LLC)into HeartSciences Inc. · Jun 23, 2026
- Serapha Bio, Inc.into Boundless Bio, Inc. · Jun 22, 2026
- Avenzo Therapeutics, Inc.into Rallybio Corporation · Jun 1, 2026
- Eos SENOLYTIX, Inc.into Pulmatrix, Inc. · Mar 26, 2026